These reelin changes were the opposite of those in DNMT-1 expression and activity, which, via the hypomethylation of the reelin promoter in acute colitis and hypermethylation in colon adenocarcinoma, increases or represses reelin expression, respectively [19,21]. The gene discussed is RELN; the disease is colon adenocarcinoma.